Ethic Inc’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.61M Sell
32,820
-4,433
-12% -$1.46M 0.15% 141
2025
Q4
$13.1M Buy
37,253
+4,245
+13% +$1.43M 0.2% 95
2025
Q3
$10.7M Sell
33,008
-6,761
-17% -$2.1M 0.18% 119
2025
Q2
$15.2M Buy
39,769
+2,564
+7% +$1.03M 0.27% 66
2025
Q1
$16.1M Buy
37,205
+12,806
+52% +$5.14M 0.33% 51
2024
Q4
$9M Buy
24,399
+5,471
+29% +$2.29M 0.18% 112
2024
Q3
$9.82M Sell
18,928
-6,118
-24% -$3.27M 0.25% 75
2024
Q2
$13.6M Buy
25,046
+6,118
+32% +$3.23M 0.32% 60
2024
Q1
$9.82M Sell
18,928
-4,858
-20% -$2.42M 0.25% 75
2023
Q4
$11.2M Buy
23,786
+2,494
+12% +$1.15M 0.33% 53
2023
Q3
$9.27M Buy
21,292
+1,831
+9% +$831K 0.33% 55
2023
Q2
$8.65M Buy
19,461
+701
+4% +$323K 0.32% 60
2023
Q1
$8.63M Buy
18,760
+65
+0.3% +$30.9K 0.35% 52
2022
Q4
$9.59M Buy
18,695
+3,099
+20% +$1.57M 0.52% 30
2022
Q3
$7.08M Buy
15,596
+1,489
+11% +$712K 0.48% 29
2022
Q2
$6.81M Buy
14,107
+2,914
+26% +$1.44M 0.47% 35
2022
Q1
$5.5M Buy
11,193
+1,741
+18% +$796K 0.38% 50
2021
Q4
$4.38M Buy
9,452
+1,654
+21% +$696K 0.34% 66
2021
Q3
$2.91M Buy
7,798
+971
+14% +$369K 0.3% 79
2021
Q2
$2.61M Buy
6,827
+1,784
+35% +$682K 0.32% 71
2021
Q1
$1.81M Buy
5,043
+1,908
+61% +$614K 0.32% 71
2020
Q4
$1.01M Buy
3,135
+465
+17% +$143K 0.27% 91
2020
Q3
$717K Buy
2,670
+492
+23% +$132K 0.27% 95
2020
Q2
$573K Buy
2,178
+607
+39% +$162K 0.33% 77
2020
Q1
$357K Buy
1,571
+232
+17% +$63.2K 0.3% 113
2019
Q4
$404K Buy
+1,339
New +$368K 0.3% 112

Other funds holding ELV

Ethic Inc's ELV Position: Q1 2026 in Review

Ethic Inc reduced its Elevance Health (ELV) stake by 12% in Q1 2026, selling an estimated $1.46M and leaving 32,820 shares worth $9.61M. The position accounts for 0.15% of the portfolio, ranked #141.

Ethic Inc first reported a position in ELV in Q4 2019 and has held it in 26 quarters since. The position peaked at $16.1M in Q1 2025. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Ethic Inc held 32,820 shares of Elevance Health worth $9.61M as of Q1 2026.
  • Ethic Inc sold 4,433 Elevance Health shares in Q1 2026, an estimated $1.46M.
  • Elevance Health made up 0.15% of Ethic Inc's portfolio in Q1 2026, its #141 holding.
  • Ethic Inc first reported a position in Elevance Health in Q4 2019 and has held it in 26 quarters since.
  • Ethic Inc's Elevance Health position peaked at $16.1M in Q1 2025.
  • 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Ethic Inc's 13F filing for Q1 2026, filed 27 Apr 2026.